© 1973 Oxford University Press
other |
Immunization During Pregnancy Against Poliomyelitis and Influenza in Relation to Childhood Malignancy
126Associate Professors of Medicine
3Associate Professor of Epidemiology (Harvard Sch. Public Health)
4Assistant Research Professor of Biometry
5Research Associate in Biometry
Boston University Medical Center 400 Totten Pond Road, Waltham, Massachusetts 02154, U. S. A.
Requests for reprints should be addressed to Dr. Dennis Slone.
In a follow-up study of 50,897 pregnancies, poliomyelitis and influenza immunizations, and viral infections were evaluated as possible risk factors for the development of malignancies in the offspring born between 1959 and 1966. Ascertainment of malignancies was based on clinical follow-up during the first year of life and on mortality experience covering the first four years of life. In 18, 342 children whose mothers were vaccinated during pregnancy with killed polio vaccine there were 14 malignancies (7.6 per 10,000) and in 32, 555 non-exposed children there were 10 (3.1 per 10,000). In the vaccinated group, nine malignancies occurred in children whose mothers were immunized during the first four lunar months of pregnancy (13.2 per 10,000). Time clustering of administration of the vaccine was evident in mothers whose children developed malignancies. There were seven tumours derived from neural tissue in the exposed children (3.8 per 10,000) and one in the non-exposed children (0.3 per 10,000). Elimination of three microscopic tumours reduced the overall rates in the exposed and non-exposed groups to 6.5 and 2.8 per 10,000, respectively. There was no evidence of an excess of malignancies in children exposed in utero to attenuated live polio vaccine, to influenza vaccine, or to spontaneous viral infections.
Received 2 July 1973
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. A. Rasmussen, D. J. Jamieson, K. MacFarlane, J. D. Cragan, J. Williams, and Z. Henderson Pandemic Influenza and Pregnant Women: Summary of a Meeting of Experts Am J Public Health, October 1, 2009; 99(S2): S248 - S254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Zaman, E. Roy, S. E. Arifeen, M. Rahman, R. Raqib, E. Wilson, S. B. Omer, N. S. Shahid, R. F. Breiman, and M. C. Steinhoff Effectiveness of Maternal Influenza Immunization in Mothers and Infants N. Engl. J. Med., October 9, 2008; 359(15): 1555 - 1564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Ayoub and F. E. Yazbak RE: "DELIVERING INFLUENZA VACCINE TO PREGNANT WOMEN" Am. J. Epidemiol., February 1, 2007; 165(3): 351 - 352. [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Naleway, W. J. Smith, and J. P. Mullooly Delivering Influenza Vaccine to Pregnant Women Epidemiol. Rev., August 1, 2006; 28(1): 47 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lindsay, L. A. Jackson, D. A. Savitz, D. J. Weber, G. G. Koch, L. Kong, and H. A. Guess Community Influenza Activity and Risk of Acute Influenza-like Illness Episodes among Healthy Unvaccinated Pregnant and Postpartum Women Am. J. Epidemiol., May 1, 2006; 163(9): 838 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Kroll, G. J. Draper, C. A. Stiller, and M. F. G. Murphy Childhood leukemia incidence in Britain, 1974-2000: time trends and possible relation to influenza epidemics. J Natl Cancer Inst, March 15, 2006; 98(6): 417 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Engels, J. Chen, R. P. Viscidi, K. V. Shah, R. W. Daniel, N. Chatterjee, and M. A. Klebanoff Poliovirus Vaccination during Pregnancy, Maternal Seroconversion to Simian Virus 40, and Risk of Childhood Cancer Am. J. Epidemiol., August 15, 2004; 160(4): 306 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Engels, H. A. Katki, P. S. Rosenberg, and M. Frisch RESPONSE: Re: Cancer Incidence in Denmark Following Exposure to Poliovirus Vaccine Contaminated With Simian Virus 40 J Natl Cancer Inst, October 15, 2003; 95(20): 1553 - 1555. [Full Text] [PDF]
|
|
|
|
|
|
R. Puntoni, M. Puntoni, and M. Ceppi Re: Cancer Incidence in Denmark Following Exposure to Poliovirus Vaccine Contaminated With Simian Virus 40 J Natl Cancer Inst, October 15, 2003; 95(20): 1552 - 1553. [Full Text] [PDF]
|
|
|
|
|
|
M. Wong, J. S. Pagano, J. T. Schiller, S. S. Tevethia, N. Raab-Traub, and J. Gruber New Associations of Human Papillomavirus, Simian Virus 40, and Epstein-Barr Virus with Human Cancer J Natl Cancer Inst, December 18, 2002; 94(24): 1832 - 1836. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y.H. Kim, I. J. Koralnik, M. LeFave, R. A. Segal, L.-A. Pfister, and S. L. Pomeroy Medulloblastomas and primitive neuroectodermal tumors rarely containpolyomavirus DNA sequences Neuro Oncology, July 1, 2002; 4(3): 165 - 170. [Abstract] [PDF]
|
|
|
|
|
|
J. S. Butel and J. A. Lednicky Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease J Natl Cancer Inst, January 20, 1999; 91(2): 119a - 134a. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gross Fisher, H. D. Strickler, P. S. Rosenberg, S. S. Devesa, J. F. Fraumeni, Jr, and J. J. Goedert SV40-Contaminated Poliovirus Vaccine and Childhood Cancer Risk JAMA, May 20, 1998; 279(19): 1527 - 1528. [Full Text] [PDF]
|
|
|
|
|
|
H. D. Strickler, P. S. Rosenberg, S. S. Devesa, J. Hertel, J. F. Fraumeni Jr, and J. J. Goedert Contamination of Poliovirus Vaccines With Simian Virus 40 (1955-1963) and Subsequent Cancer Rates JAMA, January 28, 1998; 279(4): 292 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Orenstein, A. R. Hinman, R. J. Kim-Farley, and R. A. Goodman Risks From Polio Vaccination-Reply JAMA, February 10, 1984; 251(6): 728 - 729. [Abstract] [PDF]
|
|